Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HS North America is the United States subsidiary of the Italian medical technology firm HS Hospital Service S.p.A. The company specializes in the design, manufacture, and distribution of advanced medical devices focused on minimally invasive surgery and interventional oncology. Its flagship technology, the AMICA system, provides a versatile platform for both microwave and radiofrequency ablation of soft tissue tumors in organs such as the liver, lungs, and kidneys. Additionally, the company offers a comprehensive range of specialized needles for biopsy and drainage, including the HS Trap-System for bone marrow procedures. HS North America serves the clinical community by providing high-precision tools aimed at improving patient outcomes in complex oncological and surgical interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HS North America.